Neurix and STEMCELL Technologies successfully co-hosted a live webinar on In Vitro Models of Neural Degeneration and Disease, bringing together a large and highly engaged audience from the neuroscience and stemcell research communities. The event highlighted recent advances in human in vitro models and their growing impact on both fundamental and translational neuroscience research.
The discussions throughout the webinar reflected strong interest in the reproducibility and physiological relevance of advanced neural models, twocritical challenges shaping the future of the field. STEMCELL Technologies presented multiple examples of studies leveraging their hPSC-based solutions, demonstrating how standardized tools can enable reliable and high-quality neurodegenerative disease research.
Neurix showcased its brain organoid technologies, with applications in Alzheimer’s disease modeling and innovative co-culture systems that combine glioblastoma patient-derived cells with healthy brain organoids. These models provide a unique platform to study tumor-brain interactions and to assess therapeuticeffects on both healthy and diseased tissues in parallel.
The program also featured Professor Fides Zenk (EPFL), who shared her work using brain organoids and single-cell RNA sequencing to investigate the regulatory and epigenetic mechanisms underlying early humanbrain development. Her presentation illustrated how advanced in vitro models can offer unprecedented insight into human neurodevelopment.
Overall, the webinar highlighted the complementarity of applied and fundamental approaches and reinforced the growing importance of advanced humanin vitro models in neuroscience research.
Neurix thanks STEMCELL Technologies, the invited speakers, and all participants for contributing to the success ofthe event and looks forward to continued dialogue and future collaborations.
